Double maintains 2 strategies that include VRDN - Viridian Therapeutics, Inc.
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
SGOV | -0.11% | $39.32B | 0.09% |
IYK | 0.16% | $1.51B | 0.4% |
FTXG | 0.21% | $25.83M | 0.6% |
GBIL | -0.22% | $6.30B | 0.12% |
TFLO | -0.48% | $6.75B | 0.15% |
BCI | 0.55% | $1.43B | 0.26% |
CNBS | 0.62% | $67.47M | 0.77% |
SOYB | 0.69% | $25.67M | 0.22% |
KRBN | 0.75% | $172.54M | 0.85% |
TBLL | -0.88% | $2.07B | 0.08% |
KMLM | 1.29% | $222.39M | 0.9% |
GOVZ | 1.37% | $282.60M | 0.1% |
GCC | 1.57% | $148.77M | 0.55% |
ULST | 1.65% | $586.48M | 0.2% |
UNG | -1.66% | $413.30M | 1.06% |
XHLF | -1.76% | $1.06B | 0.03% |
IXC | 1.80% | $1.81B | 0.41% |
CMDY | 1.95% | $306.32M | 0.28% |
BILZ | -1.98% | $709.20M | 0.14% |
BILS | 2.00% | $3.65B | 0.1356% |
SeekingAlpha
Immunovant, Inc. had positive results for batoclimab in trials for Myasthenia Gravis & CIDP; Thyroid Eye Disease data expected in 2025. Click for my IMVT update.
Yahoo
WALTHAM, Mass., March 10, 2025--Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biopharmaceutical company focused on discovering, developing, and commercializing potential best-in-class medicines for serious and rare diseases, today announced that a majority of the independent directors serving on the Compensation Committee of the company’s Board of Directors approved the grant of non-qualified stock options to purchase an aggregate of 113,200 shares of the company’s common stock to nine new emplo
SeekingAlpha
Viridian Therapeutics' VRDN-001 demonstrates rapid efficacy in TED. Read why VRDN stock may benefit from FDA approval and market differentiation.
Yahoo
Viridian Therapeutics ( NASDAQ:VRDN ) Full Year 2024 Results Key Financial Results Net loss: US$269.9m (loss widened by...
Yahoo
WALTHAM, Mass., February 27, 2025--Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company focused on discovering, developing and commercializing potential best-in-class medicines for serious and rare diseases, today reported recent business highlights and financial results for the fourth quarter and full year ended December 31, 2024.
Finnhub
Corporate Presentation February 2025 Viridian is building upon proven first market entrants to develop differentiated next-generation...
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
FATE | 48.39% | $97.33M | -88.43% | 0.00% |
DNLI | 45.16% | $2.15B | -27.97% | 0.00% |
CRBU | 42.90% | $87.34M | -81.73% | 0.00% |
KRNT | 41.42% | $930.84M | +7.62% | 0.00% |
TWST | 41.34% | $2.41B | +17.63% | 0.00% |
ALLO | 38.87% | $336.76M | -65.32% | 0.00% |
RGNX | 38.76% | $392.17M | -62.84% | 0.00% |
AVO | 38.58% | $719.25M | -14.74% | 0.00% |
ZYME | 37.89% | $867.72M | +17.59% | 0.00% |
MTRX | 37.66% | $345.91M | -3.84% | 0.00% |
BEAM | 37.52% | $2.22B | -32.78% | 0.00% |
ABCL | 37.10% | $688.35M | -49.01% | 0.00% |
OCUL | 36.34% | $1.21B | -16.70% | 0.00% |
BLNK | 36.24% | $94.69M | -68.91% | 0.00% |
APGE | 36.10% | $2.36B | -40.23% | 0.00% |
ATXS | 36.00% | $321.67M | -59.50% | 0.00% |
ALEC | 35.94% | $127.82M | -78.57% | 0.00% |
CRSP | 34.82% | $3.17B | -45.73% | 0.00% |
ADPT | 34.79% | $1.14B | +138.94% | 0.00% |
CELC | 34.54% | $380.21M | -52.59% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -31.22% | $393.05M | 1.43% |
VIXY | -19.66% | $195.31M | 0.85% |
TAIL | -13.78% | $84.36M | 0.59% |
USDU | -11.05% | $213.62M | 0.5% |
UUP | -9.13% | $328.64M | 0.77% |
CTA | -8.90% | $943.11M | 0.76% |
DBA | -8.59% | $823.19M | 0.93% |
DBE | -8.41% | $54.74M | 0.77% |
USCI | -6.67% | $232.14M | 1.07% |
BNO | -5.66% | $96.15M | 1% |
UGA | -5.59% | $88.53M | 0.97% |
USO | -5.56% | $947.20M | 0.6% |
DBO | -5.53% | $199.76M | 0.77% |
GSG | -5.19% | $1.04B | 0.75% |
COMT | -5.16% | $671.98M | 0.48% |
USL | -4.83% | $47.09M | 0.85% |
OILK | -4.55% | $67.10M | 0.69% |
TBIL | -4.51% | $5.33B | 0.15% |
TPMN | -3.92% | $33.38M | 0.65% |
DUSB | -3.68% | $1.14B | 0.15% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 52.34% | $5.45B | 0.35% |
GNOM | 46.02% | $55.08M | 0.5% |
ARKG | 45.29% | $971.04M | 0.75% |
IBB | 44.48% | $5.96B | 0.45% |
IWC | 43.58% | $830.00M | 0.6% |
PBE | 42.70% | $235.57M | 0.58% |
XPH | 40.18% | $166.92M | 0.35% |
FBT | 39.73% | $1.09B | 0.56% |
PTH | 39.45% | $112.97M | 0.6% |
IWO | 38.82% | $11.10B | 0.24% |
VTWO | 37.77% | $11.14B | 0.07% |
IWM | 37.51% | $65.79B | 0.19% |
BBH | 37.23% | $371.52M | 0.35% |
ONLN | 36.57% | $69.77M | 0.58% |
PINK | 36.50% | $142.47M | 0.5% |
KJAN | 36.50% | $322.07M | 0.79% |
KAPR | 36.33% | $185.09M | 0.79% |
KOMP | 36.31% | $2.01B | 0.2% |
SCHA | 36.06% | $16.28B | 0.04% |
VBK | 35.18% | $17.73B | 0.07% |
Current Value
$13.981 Year Return
Current Value
$13.981 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
PNNT | -<0.01% | - | - | 13.31% |
ALL | -0.02% | $54.71B | +19.33% | 1.82% |
CMCSA | -0.05% | $138.46B | -15.52% | 3.38% |
SU | -0.06% | $47.43B | +3.87% | 4.19% |
STNG | 0.07% | $1.91B | -46.50% | 4.27% |
ROOT | 0.08% | $2.08B | +124.18% | 0.00% |
IMMP | 0.08% | $270.74M | -20.17% | 0.00% |
CNK | -0.09% | $3.04B | +38.23% | 0.33% |
DGX | -0.10% | $18.57B | +25.71% | 1.79% |
BAX | 0.13% | $17.31B | -21.03% | 2.73% |
TW | -0.14% | $31.28B | +40.89% | 0.29% |
SAN | -0.15% | $102.78B | +40.29% | 3.17% |
PBR | 0.16% | $53.51B | -4.35% | 3.05% |
HEES | -0.18% | $3.49B | +48.69% | 1.16% |
RLI | -0.20% | $7.34B | +10.18% | 1.28% |
GDOT | 0.22% | $453.36M | -10.40% | 0.00% |
KOS | 0.23% | $1.06B | -62.75% | 0.00% |
COKE | 0.28% | $11.60B | +57.16% | 0.45% |
IP | 0.28% | $28.00B | +36.37% | 3.52% |
NTNX | -0.29% | $18.94B | +15.07% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
TSN | -15.27% | $21.78B | +6.20% | 3.17% |
CBOE | -12.34% | $23.32B | +21.20% | 1.08% |
BTCT | -11.62% | $20.00M | +13.71% | 0.00% |
TTE | -10.87% | $134.58B | -6.80% | 5.27% |
TEM | -10.62% | $8.24B | 0.00% | 0.00% |
MNOV | -9.95% | $71.12M | 0.00% | 0.00% |
CME | -9.67% | $94.50B | +21.80% | 3.99% |
BNED | -8.99% | $343.94M | -86.05% | 0.00% |
GLP | -8.61% | $1.84B | +21.74% | 5.41% |
DB | -8.54% | $45.49B | +51.93% | 2.09% |
SKWD | -8.24% | $2.11B | +40.66% | 0.00% |
CCEP | -7.78% | $39.77B | +23.37% | 2.42% |
PEP | -7.55% | $204.72B | -14.71% | 3.60% |
SCM | -7.15% | - | - | 11.39% |
T | -7.02% | $202.28B | +60.11% | 3.91% |
QNRX | -6.73% | $2.16M | -74.55% | 0.00% |
AGS | -6.21% | $500.05M | +34.97% | 0.00% |
GIS | -5.87% | $32.37B | -15.52% | 4.00% |
MO | -5.87% | $98.31B | +33.31% | 6.89% |
PULM | -5.71% | $26.26M | +310.86% | 0.00% |